Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review.
Atienza-Mateo B, Remuzgo-Martínez S, Prieto-Peña D, Mora Cuesta VM, Iturbe-Fernández D, Llorca J, Sánchez-Bilbao L, Corrales A, Blanco Rodríguez G, Gómez-Román JJ, Cifrián JM, González-Gay MÁ. Atienza-Mateo B, et al. Among authors: cifrian jm. J Clin Med. 2020 Sep 23;9(10):3070. doi: 10.3390/jcm9103070. J Clin Med. 2020. PMID: 32977717 Free PMC article.
The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation.
Atienza-Mateo B, Remuzgo-Martínez S, Mora Cuesta VM, Iturbe-Fernández D, Fernández-Rozas S, Prieto-Peña D, Calderón-Goercke M, Corrales A, Blanco Rodríguez GB, Gómez-Román JJ, González-Gay MÁ, Cifrián JM. Atienza-Mateo B, et al. Among authors: cifrian jm. J Clin Med. 2020 May 26;9(6):1606. doi: 10.3390/jcm9061606. J Clin Med. 2020. PMID: 32466389 Free PMC article.
Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease.
Remuzgo-Martínez S, Genre F, Pulito-Cueto V, Atienza-Mateo B, Mora Cuesta VM, Iturbe Fernández D, Fernández Rozas SM, Lera-Gómez L, Alonso Lecue P, Ussetti MP, Laporta R, Berastegui C, Solé A, Pérez V, De Pablo Gafas A, Gualillo O, Cifrián JM, López-Mejías R, González-Gay MÁ. Remuzgo-Martínez S, et al. Among authors: cifrian jm. Biomedicines. 2021 Apr 22;9(5):458. doi: 10.3390/biomedicines9050458. Biomedicines. 2021. PMID: 33922301 Free PMC article.
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Guillén-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Giménez BS, Colunga-Argüelles D, Revilla-López E, Rubio-Rivas M, Ropero MJC, Argibay A, Barberá JA, Salas XP, Meñaca AM, Vuelta ABM, Padrón AL, Comet LS, Morera JAD, González-Echávarri C, Mombiela T, Ortego-Centeno N, González MM, Tolosa-Vilella C, Blanco I, Subías PE, Simeón-Aznar CP; RESCLE Consortium; REHAP Consortium. Guillén-Del-Castillo A, et al. Sci Rep. 2022 Mar 28;12(1):5289. doi: 10.1038/s41598-022-09353-z. Sci Rep. 2022. PMID: 35347225 Free PMC article.
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A, Olmos JM, Cifrian JM, Gimenez T, Gandarillas MA, García-Saiz M, Rebollo MH, Martínez-Taboada V, López-Hoyos M, Fariñas MC, Crespo J. Cuadrado-Lavín A, et al. Among authors: cifrian jm. Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4. Trials. 2020. PMID: 32493494 Free PMC article.
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Guillén-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Giménez BS, Colunga-Argüelles D, Revilla-López E, Rubio-Rivas M, Ropero MJC, Argibay A, Barberá JA, Salas XP, Meñaca AM, Vuelta ABM, Padrón AL, Comet LS, Morera JAD, González-Echávarri C, Mombiela T, Ortego-Centeno N, González MM, Tolosa-Vilella C, Blanco I, Subías PE, Simeón-Aznar CP; RESCLE Consortium; REHAP Consortium. Guillén-Del-Castillo A, et al. Sci Rep. 2022 Jul 28;12(1):12947. doi: 10.1038/s41598-022-17525-0. Sci Rep. 2022. PMID: 35902683 Free PMC article. No abstract available.
Usefulness of the COVID-GRAM and CURB-65 scores for predicting severity in patients with COVID-19.
Armiñanzas C, Arnaiz de Las Revillas F, Gutiérrez Cuadra M, Arnaiz A, Fernández Sampedro M, González-Rico C, Ferrer D, Mora V, Suberviola B, Latorre M, Calvo J, Olmos JM, Cifrián JM, Fariñas MC. Armiñanzas C, et al. Among authors: cifrian jm. Int J Infect Dis. 2021 Jul;108:282-288. doi: 10.1016/j.ijid.2021.05.048. Epub 2021 May 24. Int J Infect Dis. 2021. PMID: 34044145 Free PMC article.
41 results